Support Burnet’s COVID-19 emergency response
COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
Antibodies are key effector molecules responsible for mediating protection against many other infectious diseases.
This project will involve engineering novel recombinant antibodies against malaria parasite proteins and those of other infectious diseases organisms.
These will then be used in a range of in vitro immunological assays to determine their precise functional mechanisms and efficacy in protective immunity.
For any general enquiries relating to this project, please contact:
Group Head, NHMRC Postdoctoral Fellow, Infectious Diseases Physician
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2020 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung and Wurundjeri people and we offer our respects to the elders past and present.
We recognise and respect the cultural heritage of this land.
